Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, Pérez Valdivia MÁ, Wu MS, Susan Huang SH, Alamartine E, Kim SG, Yee M, Kateifides A, Rice K, Garlo K, Barratt J; SANCTUARY Study Investigators. Lafayette R, et al. J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39455063 No abstract available.
Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy.
Barratt J, Barbour S, Brenner R, Cooper K, Wei X, Eren N, Floege J, Jha V, Kim SG, Maes B, Phoon RKS, Singh H, Tesař V, Lafayette R; ORIGIN Phase 2b Investigators. Barratt J, et al. Among authors: lafayette r. J Am Soc Nephrol. 2024 Oct 26. doi: 10.1681/ASN.0000000541. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39462308 No abstract available.
Clinical and Humanistic Burden of IgAN in Adult Patients: A Global Real-World Survey.
Tang SCW, Wei C, Aldworth C, George AT, Kattlun J, Tomas GR, Kroes M, Roccatello D, Przybysz R, Smeets S, Golden K, Garratt-Wheeldon J, Chatterton E, de Courcy J, Lafayette R. Tang SCW, et al. Among authors: lafayette r. Kidney360. 2024 Oct 22. doi: 10.34067/KID.0000000613. Online ahead of print. Kidney360. 2024. PMID: 39437219 Free article.
Preparation and Rationale for a Patient-Centered Clinical Outcome Assessment Set of Fluid Overload for Drug Development in Nephrotic Syndrome.
Salmon E, Carlozzi NE, Lai JS, Spino C, Wang Y, Capellari E, Scherr R, Sifre K, Sullivan S, Hurt C, Creguer T, Helm K, Lafayette RA, Nachman PH, Selewski DT, Peipert JD. Salmon E, et al. Among authors: lafayette ra. Glomerular Dis. 2024 Aug 5;4(1):172-182. doi: 10.1159/000539921. eCollection 2024 Jan-Dec. Glomerular Dis. 2024. PMID: 39473996 Free PMC article.
Atrasentan in Patients with IgA Nephropathy.
Heerspink HJL, Jardine M, Kohan DE, Lafayette RA, Levin A, Liew A, Zhang H, Lodha A, Gray T, Wang Y, Renfurm R, Barratt J; ALIGN Study Investigators. Heerspink HJL, et al. Among authors: lafayette ra. N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2409415. Online ahead of print. N Engl J Med. 2024. PMID: 39460694
Deconvolution of Human Urine across the Transcriptome and Metabolome.
Vorperian SK, DeFelice BC, Buonomo JA, Chinchinian HJ, Gray IJ, Yan J, Mach KE, La V, Lee TJ, Liao JC, Lafayette R, Loeb GB, Bertozzi CR, Quake SR. Vorperian SK, et al. Among authors: lafayette r. Clin Chem. 2024 Nov 4;70(11):1344-1354. doi: 10.1093/clinchem/hvae137. Clin Chem. 2024. PMID: 39383112
162 results